Skip to Main Content

Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue Pharma said they would not proceed with plans to contribute more than $4.3 billion to settle massive litigation over the opioid crisis unless they are granted immunity from all existing and future legal claims.

David Sackler, 41, who is a former Purdue board member and grandson one of the founders of the drug maker, acknowledged the family has a “moral responsibility to try and help, and that’s what this settlement is designed to do.” But he also maintained that without receiving a global release from legal liability, the carefully crafted settlement would fall apart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment